Viemed posts record FY2025 revenue $270.3M; net income +33%; guides FY2026 rev $310-320M

VIEMED HEALTHCARE, INC.

Q4 revenue $76.2M (record, +26% YoY); FY revenue $270.3M (record, +21% YoY).
FY2025 net income $14.9M ($0.37 diluted EPS), +33% YoY; adjusted EBITDA record $61.4M.
FY2025 operating cash flow $51.9M; free cash flow $28.1M (more than doubled YoY).
2026 guidance: revenue $310-320M, adjusted EBITDA $65-69M, capex 10-11.5% of revenue.
Board authorized share repurchase of up to 1,930,131 shares (~5% outstanding) through March 2027.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.